Amwell (AMWL) Misses Q2 EPS by 316c
Tweet
Share
E-mail
Get Alerts AMWL Hot Sheet
Join SI Premium – FREE
Amwell (NYSE: AMWL) reported Q2 EPS of ($3.36), $3.16 worse than the analyst estimate of ($0.20). Revenue for the quarter came in at $62.8 million versus the consensus estimate of $61.62 million.
For earnings history and earnings-related data on Amwell (AMWL) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Jana Partners urges Cooper Companies to replace CEO and explore asset sales
- Xenon Pharmaceuticals (XENE) PT Lowered to $60 at Needham
- Restaurant Brands International (QSR) PT Raised to $86 at Guggenheim
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
